PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101. PL 110-275, Medicare Improvement for Patients and Providers Act of 2008, Section 203, pharmacy reimbursement under Medicaid; H.R. 573, Bill to prohibit authorized generics during period of exclusivity; S. 501, Fair Prescription Drug Competition Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; S. 369 (Preserve Access to Affordable Generics Act); H.R. 3962, the Affordable Health Care for America Act, Sections 1741, 2501, 2502, 2573; H.R. 3590, the Patient Care and Affordable Protection Act, Sections 2501, 2503, 7101.
HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ALSTON & BIRD LLP
THE ATLANTIC BUILDING, 950 F STREET, NW, WASHINGTON, DC, 20004, US
MARK RAYDER MARK RAYDER